Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
JTO Clinical and Research Reports|March 19, 2026
Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter StudyAkito Miyazaki, Kinnosuke Matsumoto, Motohiro Tamiya, et al.
JCI Insight|October 25, 2022
Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cellsYuta Yamaguchi, Yasuhiro Kato, Ryuya Edahiro, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2012
Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrityKazuyuki Tsujino, Yoshito Takeda, Toru Arai, et al.
Thoracic Cancer|June 3, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective StudyKeijiro Yamauchi, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2021
IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor ImmunityYasuhiko Suga, Izumi Nagatomo, Yuhei Kinehara, et al.
JCI Insight|April 7, 2022
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancerKentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
Inflammation and Regeneration|December 1, 2022
Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19Takahiro Kawasaki, Yoshito Takeda, Ryuya Edahiro, et al.
Cancer Research|June 5, 2012
Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesisShoichi Ihara, Hiroshi Kida, Hisashi Arase, et al.
Annals of the Rheumatic Diseases|June 26, 2022
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic componentYuya Shirai, Yoshimitsu Nakanishi, Akari Suzuki, et al.
International Journal of Molecular Sciences|February 13, 2025
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular VesiclesMaiko Naito, Yoshito Takeda, Ryuya Edahiro, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
JTO Clinical and Research Reports|March 19, 2026
Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter StudyAkito Miyazaki, Kinnosuke Matsumoto, Motohiro Tamiya, et al.
JCI Insight|October 25, 2022
Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cellsYuta Yamaguchi, Yasuhiro Kato, Ryuya Edahiro, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2012
Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrityKazuyuki Tsujino, Yoshito Takeda, Toru Arai, et al.
Thoracic Cancer|June 3, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective StudyKeijiro Yamauchi, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2021
IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor ImmunityYasuhiko Suga, Izumi Nagatomo, Yuhei Kinehara, et al.
JCI Insight|April 7, 2022
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancerKentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
Inflammation and Regeneration|December 1, 2022
Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19Takahiro Kawasaki, Yoshito Takeda, Ryuya Edahiro, et al.
Cancer Research|June 5, 2012
Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesisShoichi Ihara, Hiroshi Kida, Hisashi Arase, et al.
Annals of the Rheumatic Diseases|June 26, 2022
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic componentYuya Shirai, Yoshimitsu Nakanishi, Akari Suzuki, et al.
International Journal of Molecular Sciences|February 13, 2025
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular VesiclesMaiko Naito, Yoshito Takeda, Ryuya Edahiro, et al.
Pageof 15